In a patient with rheumatoid arthritis who has no risk factors for syphilis, is a rapid plasma reagin (RPR) test necessary or useful?

RPR Testing in Rheumatoid Arthritis Patients Without Syphilis Risk Factors

An RPR test is not necessary or useful in a patient with rheumatoid arthritis who has no risk factors for syphilis. The test should only be performed when there is clinical suspicion of syphilis based on epidemiologic risk factors or clinical manifestations.

Rationale

When RPR Testing Is Indicated

According to CDC guidelines, syphilis screening with nontreponemal tests (RPR or VDRL) is recommended for specific populations 1, 2:

• Pregnant women (mandatory screening at first prenatal visit, with repeat testing in third trimester and at delivery for high-risk women)
• Persons with high-risk behaviors: sex workers, illicit drug users, MSM, those with multiple sexual partners
• Persons in high-prevalence communities (southern United States, certain metropolitan areas)
• Individuals with symptoms suggestive of syphilis (genital ulcers, rash involving palms/soles, lymphadenopathy)
• Sexual contacts of persons diagnosed with syphilis

Why RPR Is Not Useful in Low-Risk RA Patients

False-positive nontreponemal tests are well-documented in rheumatoid arthritis and other autoimmune conditions. The evidence shows:

• In presumed normal populations, RPR has false-positive rates of 0.4-5.2% depending on the test method 3
• Rheumatoid factor (RF), present in most RA patients, can interfere with syphilis serologic testing and cause false-positive results 4
• RF occurrence increases with disease duration and is found in 1/13 primary syphilis cases, 3/13 secondary cases, and 10/27 latent cases—but these represent true syphilis infections with concurrent RF, not false positives 4

The specificity of RPR ranges from 71.8-99.8% depending on the population and test method 3. In a patient without risk factors, a positive result would most likely represent a false positive requiring additional confirmatory treponemal testing (FTA-ABS or TP-PA), causing unnecessary anxiety, cost, and clinical evaluation 2.

Clinical Algorithm for Syphilis Testing

Test only when:

1. Patient has epidemiologic risk factors (sexual exposure, drug use, high-prevalence area)
2. Clinical signs/symptoms suggest syphilis (chancre, rash, lymphadenopathy, neurologic symptoms)
3. Pregnancy (universal screening mandated)
4. Sexual contact with diagnosed syphilis case

Do not test when:

• No sexual risk factors present
• No clinical manifestations
• Routine screening in low-risk populations
• Solely because of autoimmune disease diagnosis

Important Caveats

• If syphilis testing is performed for any reason, use the two-step approach: nontreponemal test (RPR/VDRL) followed by confirmatory treponemal test (FTA-ABS/TP-PA) for any reactive result 1, 5
• Never diagnose syphilis based on RPR alone in patients with autoimmune conditions
• The presence of rheumatoid arthritis does not change the performance characteristics of syphilis tests in patients who actually have syphilis 5
• Some laboratories now use reverse sequence testing (treponemal test first), which may identify more patients with prior treated syphilis 5, 6

In summary, routine RPR screening in RA patients without syphilis risk factors has no clinical utility, generates false-positive results requiring additional workup, and should not be performed.